Projects funded by the NCN
Influence of PPAR-gama receptor agonists on antitumor activity of photodynamic therapy.
2012/05/N/NZ5/02616
Keywords:
PPAR-gamma ligand reactive oxygen species PPAR-gamma cancers photodynamic therapy
Descriptors:
- NZ5_7: Human disease treatment
- NZ5_9: Other related subjects
Panel:
NZ5 - Human and animal noninfectious diseases: etiology, mechanisms, diagnosis and treatment of diseases, poisonings and injuries (without neurological diseases)
Host institution :
Warszawski Uniwersytet Medyczny, Wydział Nauki o Zdrowiu
woj. mazowieckie
Principal investigator (from the host institution):
Number of co-investigators in the project: 2
Call: PRELUDIUM 3 - announced on 2012-03-15
Amount awarded: 98 020 PLN
Project start date (Y-m-d): 2013-03-12
Project end date (Y-m-d): 2015-03-11
Project duration:: 24 months (the same as in the proposal)
Project status: Project settled
Information in the final report
- Publication in academic press/journals (1)
- PPARγ ligands increase antileukemic activity of second- and third-generation tyrosine kinase inhibitors in chronic myeloid leukemia cells.Authors:E Glodkowska-Mrowka, A Manda-Handzlik, A Stelmaszczyk-Emmel, I Seferynska,3 T Stoklosa,J Przybylski, P MrowkaAcademic press:Blood Cancer Journal (rok: 2016, tom: 6, strony: e377), Wydawca: Nature Publishing GroupStatus:PublishedDOI:10.1038/bcj.2015.109 - link to the publication